Abstract
During its development in the host red cell, the human malarial parasite causes profound alteration in the permeability of the host cell membrane. These membrane transport systems(s) play a role in the development of the intra-erythrocytic parasite in its need to take up solutes and nutrients from the extracellular medium and the disposal of metabolic wastes. Importantly, the properties of these parasite induced transport systems are significantly different from those in normal human cells. Hence, such systems are of considerable interest for their potential use in anti-malarial chemotherapy, both by (i) inhibiting the transport and hence depriving the parasite of nutrients essential for its development, or (ii) by designing cytotoxic drugs which selectively enter the parasite through these induced transporter routes and hence cannot enter normal mammalian cells. Since our discovery that optical isomers of nucleosides (such as Ladenosine or L- thymidine) were selectively transported into malaria infected cells through the induced transporter, L-nucleoside drug “carriers” were actively synthesized as potentially new therapeutic agents. The compounds are dinucleoside phosphate dimers, where each ”carrier“ (a L-nucleoside) has been conjugated to known anti-malarial agents, such as 5-fluro-uridine through the 3 and 5-OH and a phosphate group. A very large series of these drugs have been synthesized with varying conjugations. The dimers are extremely toxic against malaria and experimental evidence has confirmed that they are incapable of entering normal mammalian cells. This review discusses their mechanism of action and potential as new anti-malarial chemotherapy as well as the role played by the membrane transport system of malaria infected cells as a target for malaria chemotherapy.
Keywords: Malaria, Chemotherapy, isomers, fluro-uridine, anti-malarial agents, mammalian cells, L- thymidine
Current Pharmaceutical Design
Title: New Malaria Chemotherapy Developed by Utilization of a Unique Parasite Transport System
Volume: 9 Issue: 11
Author(s): Annette M. Gero, Catherine G. Dunn, David M. Brown, Kirupa Pulenthiran, Elena L. Gorovits, Tomas Bakos and Alexander L. Weis
Affiliation:
Keywords: Malaria, Chemotherapy, isomers, fluro-uridine, anti-malarial agents, mammalian cells, L- thymidine
Abstract: During its development in the host red cell, the human malarial parasite causes profound alteration in the permeability of the host cell membrane. These membrane transport systems(s) play a role in the development of the intra-erythrocytic parasite in its need to take up solutes and nutrients from the extracellular medium and the disposal of metabolic wastes. Importantly, the properties of these parasite induced transport systems are significantly different from those in normal human cells. Hence, such systems are of considerable interest for their potential use in anti-malarial chemotherapy, both by (i) inhibiting the transport and hence depriving the parasite of nutrients essential for its development, or (ii) by designing cytotoxic drugs which selectively enter the parasite through these induced transporter routes and hence cannot enter normal mammalian cells. Since our discovery that optical isomers of nucleosides (such as Ladenosine or L- thymidine) were selectively transported into malaria infected cells through the induced transporter, L-nucleoside drug “carriers” were actively synthesized as potentially new therapeutic agents. The compounds are dinucleoside phosphate dimers, where each ”carrier“ (a L-nucleoside) has been conjugated to known anti-malarial agents, such as 5-fluro-uridine through the 3 and 5-OH and a phosphate group. A very large series of these drugs have been synthesized with varying conjugations. The dimers are extremely toxic against malaria and experimental evidence has confirmed that they are incapable of entering normal mammalian cells. This review discusses their mechanism of action and potential as new anti-malarial chemotherapy as well as the role played by the membrane transport system of malaria infected cells as a target for malaria chemotherapy.
Export Options
About this article
Cite this article as:
Gero M. Annette, Dunn G. Catherine, Brown M. David, Pulenthiran Kirupa, Gorovits L. Elena, Bakos Tomas and Weis L. Alexander, New Malaria Chemotherapy Developed by Utilization of a Unique Parasite Transport System, Current Pharmaceutical Design 2003; 9 (11) . https://dx.doi.org/10.2174/1381612033455233
DOI https://dx.doi.org/10.2174/1381612033455233 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Elimination, Containment, and Mitigation of COVID-19: A Personal Story
about International Travels
Current Pediatric Reviews Natural Products as α-Amylase and α-Glucosidase Inhibitors and their Hypoglycaemic Potential in the Treatment of Diabetes: An Update
Mini-Reviews in Medicinal Chemistry Drug Targets from Human Pathogenic Amoebas: Entamoeba histolytica,Acanthamoeba polyphaga and Naegleria fowleri
Infectious Disorders - Drug Targets Peptide-based Vaccines in the Treatment of Specific Allergy
Current Drug Targets - Inflammation & Allergy Meet Our Editor-in-Chief:
Current Proteomics Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview
Current Molecular Medicine Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants
Current Pharmaceutical Design Porcine Epidemic Diarrhea: Causative Agent, Epidemiology, Clinical Characteristics, and Treatment Strategy Targeting Main Protease
Protein & Peptide Letters Search for Molecular Basis of Antifungal Activity of Thiosemicarbazide Derivatives: A Combined in vitro Antifungal and Enzymatic Studies with in Silico Docking
Letters in Drug Design & Discovery Recent Advances in the Development of MMPIs and APNIs Based on the Pyrrolidine Platforms
Mini-Reviews in Medicinal Chemistry Recovery of a 91-year-old COVID-19 Patient with Medical and Psychological Support
Current Chinese Science Triamcinolone as a Potential Inhibitor of SARS-CoV-2 Main Protease and Cytokine Storm: An <i>In silico</i> Study
Letters in Drug Design & Discovery Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of Stem Cells: A Narrative Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets Exploring the Multitarget Potential of Iridoids: Advances and Applications
Current Topics in Medicinal Chemistry The Fate of Nanocarriers As Nanomedicines In Vivo: Important Considerations and Biological Barriers to Overcome
Current Medicinal Chemistry Editorial
Protein & Peptide Letters Inhibition of the Interaction between HIV-1 Integrase and its Cofactor LEDGF/p75: A Promising Approach in Anti-Retroviral Therapy
Mini-Reviews in Medicinal Chemistry Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19
Current Medicinal Chemistry Assessment of Stress, Anxiety, and Depression Levels Among COVID-19 Positive Patients Admitted in Rural Tertiary Care Hospital
Coronaviruses The Recent Trend in QSAR Modeling - Variable Selection and 3D-QSAR Methods
Current Computer-Aided Drug Design